Factors determining quality of life in patients with remitting multiple sclerosis
Popova, E.V.
Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(4): 77-80
2008
ISSN/ISBN: 1997-7298 PMID: 18567195 Document Number: 618058
Document emailed within 1 workday
Related Documents
Laosanguanek, N.; Wiroteurairuang, T.; Siritho, S.; Prayoonwiwat, N. 2011: Reliability of the Thai version of SF-36 questionnaire for an evaluation of quality of life in multiple sclerosis patients in multiple sclerosis clinic at Siriraj Hospital Journal of the Medical Association of Thailand 94 Suppl. 1: S84-S88Fernández-Fernández, O. 2002: Clinical features of relapsing remitting-multiple sclerosis. Prognostic factors Revista de Neurologia 35(11): 1067-1073
Talarska, D.; Brzozowska, E. 2003: Quality of life of patients with multiple sclerosis Neurologia i Neurochirurgia Polska 37(3): 561-571
Losy, J.; Niezgoda, A.; Zaremba, J.ła. 2002: IL-15 is elevated in sera of patients with relapsing-remitting multiple sclerosis Folia Neuropathologica 40(3): 151-153
Lebedeva, A.V.; Shchukin, I.A.; Soldatov, M.A.; Boĭko, O.V.; Petrov, S.V.; Khozova, A.A.; Ismailov, A.M.; Shikhkerimov, R.K.; Boĭko, A.N. 2014: Asthenia, emotional disorders and quality of life of patients with multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(10 Part 2): 99-104
Belenko, E.A.; Vorob'eva, O.V. 2012: Characteristics of the autonomous control of cardiac activity in patients with remitting multiple sclerosis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 112(3 Part 1): 68-71
Pietropaolo, V.; Fioriti, D.; Mischitelli, M.; Anzivino, E.; Santini, M.; Millefiorini, E.; Di Rezze, S.; Degener, A.Marta. 2005: Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis New Microbiologica 28(3): 199-203
Pokryszko-Dragan, A.; Bilińska, M.łg.; Gruszka, E.; Dubik-Jezierzańska, M. 2005: Clinical assessment of the course of relapsing-remitting multiple sclerosis in patients treated with interferon beta Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 19(113): 654-658
Cabrera-Gómez, J.A.; Echazábal-Santana, N.; Porrero-Martín, P.; Valenzuela-Silva, C.; Rodríguez, C.A.; Fuentes-Suárez, I.; Pérez-Ruiz, L.; Ramos-Cedeño, A.M.; Cabrera-Núñez, J.A. 2003: Interferon-alpha2b recombinant improved the cognitive dysfunction in patients with relapsing remitting multiple sclerosis Revista de Neurologia 37(3): 214-220
Stelmasiak, Z.; Bartosik-Psujek, H.; Belniak-Legieć, E.; Mitosek-Szewczyk, K. 2000: The effect of cladribine on some parameters of blood and cerebrospinal fluid in patients with relapsing-remitting multiple sclerosis (RR-MS) Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 55: 221-225
Adamczyk-Sowa, M.; Pierzchala, K.; Sowa, P.; Polaniak, R.; Kukla, M.; Hartel, M. 2014: Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 65(4): 543-550
Le-Page, E.; Leray, E.; Taurin, G.; Coustans, M.; Chaperon, J.; Edan, G. 2006: Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients Revue Neurologique (Paris) 162(2): 185-194
Bilińska, M.łg.; Frydecka, I.; Kosmaczewska, A.; Ciszak, L.; Koszewicz, M.; Pokryszko-Dragan, A. 2006: CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 20(115): 41-45
Popova, E.V.; Brylev, L.V.; Davydovskaia, M.V. 2013: Natalizumab in the treatment of patients with relapsing-remitting multiple sclerosis: the preliminary results of the observational program "Sovet" Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(2 Pt 2): 79-82
Al-Tahan, A.M.; Al-Jumah, M.A.; Bohlega, S.M.; Al-Shammari, S.N.; Al-Sharoqi, I.A.; Dahdaleh, M.P.; Hosny, H.M.; Yamout, B.I. 2011: The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory Group Neurosciences 16(2): 109-113
Wang, Q.-x.; Yan, Y.-p.; Ji, Z.-h.; Ni, Q.-r.; Song, Y.-p.; Li, S.-t.; Xie, J.; Ren, J.-j.; Guo, L.; Dai, J.-q. 2013: Study on the quality of life and its related factors on patients with multiple myeloma Zhonghua Liu Xing Bing Xue Za Zhi 34(12): 1233-1236
Hennemann, A. 2002: Glatiramer for relapsing-remitting multiple sclerosis Medizinische Monatsschrift für Pharmazeuten 25(4): 141-142
Opara, J.óz.; Szwejkowski, W.; Brola, W. 2008: Quality of life in visual disturbances in multiple sclerosis Wiadomosci Lekarskie 61(1-3): 62-66
Grimaud, J.; Auray, J.P.; Collectif-Sep-Des-Villes-Et-Sep-Des-Champs 2004: Quality of life and economic cost of multiple sclerosis Revue Neurologique (Paris) 160(1): 23-34
Delgado-Mendilívar, J.M.; Cadenas-Díaz, J.C.; Fernández-Torrico, J.M.; Navarro-Mascarell, G.; Izquierdo, G. 2005: A study of the quality of life in cases of multiple sclerosis Revista de Neurologia 41(5): 257-262